| Literature DB >> 29106783 |
Maria Brzozowska1, Ewa Bieniek1, Konrad Szosland1, Andrzej Lewinski1.
Abstract
Gestational diabetes (GDM) is a relatively common complication of pregnancy. Maternal hyperglycemia causes many serious side effects for mothers, fetuses and newborns. In 90% of women diagnosed with GDM, a dietary treatment results in satisfactory levels of blood glucose. The remaining 10% require insulin therapy to achieve the recommended glycemic levels. The majority of recent studies show the efficiency of metformin in gestational diabetes and prove that it is not a cause for any harmful side effects to the embryo and/or fetus. Metformin is an effective alternative to insulin in glycemic control in pregnant women. The implementation of metformin, as a routine procedure in gestational diabetes, requires further research, the results of which would unequivocally confirm its efficacy and safety for pregnant women and their offspring.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29106783
Source DB: PubMed Journal: Neuro Endocrinol Lett ISSN: 0172-780X Impact factor: 0.765